A carregar...

A novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthma

Drug resistance and the harmful side effects accompanying the prolonged corticosteroid treatment of chronic pulmonary diseases prompted the development of more specific anti-inflammatory approaches. Several strategies aiming to block IL4Rα, the receptor for a key pro-inflammatory pathway, were inves...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Mol Med
Main Authors: Halwani, Rabih, Sultana Shaik, Asma, Ratemi, Elaref, Afzal, Sibtain, Kenana, Rosan, Al-Muhsen, Saleh, Al Faraj, Achraf
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5099422/
https://ncbi.nlm.nih.gov/pubmed/27713399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2016.89
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!